Clinical improvement (dichotomous) · inactive EoE patients
It is very uncertain whether leukotriene receptor antagonist changes clinical improvement at 26 weeks (dichotomous) compared with placebo (very low certainty).
1 finding from 1 review
FEV1 % predicted · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FVC · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Growth and nutritional status · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of infective pulmonary exacerbations: number of exacerbations per patient year · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Isolation of other micro‐organisms from the respiratory tract: number of positive cultures per patient year · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects of antibiotics: number of participants reporting a serious adverse event · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of PDR/CSME/VH by 5 years · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Change in visual loss associated with PSR: visual loss is defined by the deterioration of visual acuity of 3 lines or more with the Snellen chart · type 1 or type 2 diabetics
It is very uncertain whether blood pressure intervention/intensive blood pressure intervention changes visual acuity (loss of 3 lines or more) by 5 years compared with placebo/standard blood pressure intervention (very low certainty).
1 finding from 1 review
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Adverse events: hypotension · type 1 or type 2 diabetics
Blood pressure intervention/intensive blood pressure intervention may leads to higher adverse events—hypotension compared with placebo/standard blood pressure intervention (low certainty).
1 finding from 1 review
Intervention not reported
Gestational diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)
It is very uncertain whether the intervention changes gestational diabetes mellitus (very low certainty).
1 finding from 1 review
Intervention not reported
Composite of serious neonatal outcomes · infants of pregnant women
1 finding from 1 review
Intervention not reported
Neonatal hypoglycaemia · infants of pregnant women
It is very uncertain whether the intervention changes neonatal hypoglycaemia (very low certainty).
1 finding from 1 review
Intervention not reported
Adiposity · infants of pregnant women
1 finding from 1 review
Intervention not reported
Diabetes · infants of pregnant women
1 finding from 1 review
Intervention not reported
Neurosensory disability · infants of pregnant women
1 finding from 1 review
Intervention not reported
Weight gain during pregnancy · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)
1 finding from 1 review
Intervention not reported
Hypertensive disorders of pregnancy · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)
The intervention may leads to lower hypertensive disorders of pregnancy (low certainty).
1 finding from 1 review
Intervention not reported
Caesarean section · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)
The intervention showed no clear difference in caesarean section (low certainty).
1 finding from 1 review